Ary DELERAY

• Sourcing and commercial evaluation of in/out-licensing, co-marketing and co-promotion opportunities (global, european and local scales)
• Financial modeling : Sales forecasts, commercial expenses and P&L simulations, deal structure modeling
• Support to the negotiation of a major deal
• Market research with analysis and monitoring of sales performance and of promotion
• Competitive intelligence, screening of product portfolios and of development pipelines
• Support to the realization of capabilities presentations to potential partners (local managing director level)

• Participate to the establishment of a strategic partnership for a phase IIa compound for the treatment of Alzheimer's Disease:
- Identification and selection of key potential partners
- Sales forecasts
- Due diligence activities
- Business and R&D intelligence

• Prospection for an R&D alliance: Evaluation and recommendation of potential partners based on ExonHit’s value proposition

• Exploratory evaluation of an R&D collaboration opportunity in the diagnostic area: market research with analysis of scientific and clinical perspectives and problematics, financial modeling

• Participate to the out-licensing of a chemical compound intented to research purposes: initial contacts, sales forecasts, direct support for contract negotiation and conclusion

• Participate to the marketing activities related to the launch of a blood-based Alzheimer diagnostic test on the RUO market:
- Competitive intelligence including data collection & analysis, strategic recommendations to the Sr management and creation of an internal database
- Contribution to the Business plan's elaboration (financial modelization, market research on the clinical research and the clinical diagnostic markets)
- Operational marketing (communication plan, launch plan, participation to medical conferences ...)

Researched for a specialization project on therapeutic recombinant proteins (TRP) at ENSAIA. In charge of the recombinant proteins’ business analysis:
- International market
- Investment and costs key issues
- Compilation of economic figures on key families
- Weight in pharma's R&D pipelines
- Main therapeutic orientations
- French TRP market analysis
- Future prospects

Member of the ENSAIA’s Junior-Company : Agroalimentaire Développement Nancy (A.D.N., entirely managed by students)
Managed the prospection division (eight students):
- Managed the operational prospection of local and large companies
- Defined the strategic business areas of prospection
- Managed an 8-month contract of 5 000€ with the A.N.D.R.A. (French National Radioactive Waste Management Agency)
- Supervized the implementation of an information system
- Managed the implementation of the new student-recruitment and quality-control procedures